Impact of tricyclic antidepressants, selective serotonin reuptake inhibitors, and other antidepressants on overall survival of patients with advanced lung cancer from 2004 to 2014: University of Cincinnati experience

Nagla Abdel Karim,Rammey Hassan,Nabeela Iffat Siddiqi,Ihab Eldessouki,Ola Gaber,Mohamed Rahouma,Mohamed Kamel,Mhender Yellu,Shuchi Gulati,Changchun Xie,Mohamed Magdy,Jane M. Pruemer

Impact of tricyclic antidepressants, selective serotonin reuptake inhibitors, and other antidepressants on overall survival of patients with advanced lung cancer from 2004 to 2014: University of Cincinnati experience

2019

Nagla Abdel Karim
Rammey Hassan
Nabeela Iffat Siddiqi
Ihab Eldessouki
Ola Gaber
Mohamed Rahouma
Mohamed Kamel
Mhender Yellu
Shuchi Gulati
Changchun Xie
Mohamed Magdy
Jane M. Pruemer

ObjectivesTo evaluate and categorize the survival benefit of tricyclic antidepressants (TCAs) in lung cancer patients based on systematic computational drug repositioning data.MethodsData were retr...

Keywords:

Oncology
Anesthesia
Reuptake inhibitor
Diabetes mellitus
Medicine
Tricyclic
Drug repositioning
Serotonin
Internal medicine
Lung cancer
overall survival
MEDLINE
survival benefit
serotonin reuptake

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations